[1] [12] NICE guidance (NG28) recommends considering a reduction in insulin or sulfonylurea doses when initiating or uptitrating GLP-1 receptor agonists
Future research should focus on improving study quality, standardizing methodologies, the adoption of a standard outcome measure, and expanding representation to improve our understanding of the efficacy and safety of AOMs in this region
Semaglutide medications like Wegovy carry expiration dates for critical reasons: beyond that date, the active compound degrades and sterility cannot be guaranteed
Medications are HSA and FSA eligible, and pricing is transparent and affordableranging from $129/mo to $349/mo depending on the specific medication and formulation you choose
They have come into the limelight after a large double-blinded study published in NEJM, showed an average 14.9% decrease in weight in obese patients given semaglutide on top of lifestyle modifications, compared to 2.4% in the control arm (see research summary at end)